Regentis Biomaterials (RGNT) Retained Earnings (2024 - 2025)
Regentis Biomaterials (RGNT) reported Retained Earnings of -$55.8 million for Q4 2025, down 32.38% year-over-year from -$82.5 million in Q4 2024, and down 32.38% quarter-over-quarter from -$42.1 million in Q4 2024.
Regentis Biomaterials (RGNT) Retained Earnings (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Retained Earnings data on file, last reported at -$55.8 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$55.8 million, down 32.38% year-over-year; the trailing twelve-month figure through Dec 2025 was -$55.8 million (down 32.38% YoY), and the FY2025 annual result was -$55.8 million, down 32.38% from the prior year.
- Retained Earnings slipped to -$55.8 million in Q4 2025 per RGNT's latest filing, from -$42.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$42.1 million in Q4 2024 and troughed at -$55.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 6.40 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 17.39 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 122.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 6.96 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.48 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -670.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 7.70 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 70.09 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.69 Bn |
| 10 | Regentis Biomaterials | 3.72 Mn | -3.66 Mn | - | -55.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -55.79 Mn |
| Dec 31, 2024 | -42.15 Mn |